Cialis maker will participate in investment conference
January 23, 2006

ICOS Corporation, the maker of erectile dysfunction drug Cialis had announced today that it will participate in the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference on Thursday, February 9, 2006. The presentation, which may include a discussion of financial guidance and future plans, will be webcast in real-time and a replay will be available through February 16, 2006.

ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS is marketing its first product, Cialis(R) (tadalafil), for the treatment of erectile dysfunction. ICOS is working to develop treatments for serious unmet medical conditions such as pulmonary arterial hypertension, benign prostatic hyperplasia, hypertension, cancer and inflammatory diseases.

To read more, visit….. http://www.genengnews.com/news/bnitem.aspx?name
=1150290XSL_NEWSML_TO_NEWSML.xml